FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments
Gilead Science's remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.
Read more on NPR
Health & Science - March 25, 2020 at 06:26AM - FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments
Không có nhận xét nào:
Đăng nhận xét